GSK plc
Search results
Jun 17, 2024 · Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better. Explore Career Opportunities.
In India since 1956, we offer innovative solutions in preventive healthcare (vaccines) as well as in treatment for allergy, pain, diabetes, rare diseases, and other therapeutic areas. READ MORE. Why join Sanofi?
Jun 13, 2024 · The company's established presence in chronic therapies with a focus on diabetology, cardiology, gastro, and CNS products, rationalisation of operations and new product launches are expected to drive profitability and bolster its growth, the company said in its 2024 annual report.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...
Global pharmaceutical company Sanofi chases the miracles of science to deliver medicines and vaccines for millions of people around the world.
Sanofi India Limited is one of the entities of Sanofi in India. Present in the country since 1956, it was born under the name of Hoechst Fedco Pharma Private Limited.
We, at Sanofi, are there beside people to support them during their health challenges. We aim to prevent illnesses through our vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and millions with long-term chronic conditions.
Home Page. Science & Innovation. Pharmaceutical products. Always use our prescription products under medical supervision. Contact us.
Sep 28, 2006 · Download PDF. Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate. High seroconversion across the three dosages tested and comparable tolerability to other unmodified mRNA COVID-19 vaccines.
Learn about Sanofi, a leading global pharmaceutical company in the US, advancing specialty care, vaccines, and consumer healthcare.
